Business description: Endologix, Inc.

Endologix, Inc. develops, manufactures, markets and sells medical devices for the treatment of aortic disorders. The Company's products are designed for the minimally-invasive endovascular treatment of abdominal aortic aneurysms (AAA). Its AAA products are developed on one of two platforms: traditional minimally-invasive endovascular aneurysm repair (EVAR) or endovascular aneurysm sealing (EVAS), the Company's solution for sealing the aneurysm sac while maintaining blood flow. The Company's EVAR products include the AFX Endovascular AAA System (AFX System), the VELA Proximal Endograft (VELA) and the Ovation Abdominal Stent Graft System (Ovation System). The Company's EVAS product is the Nellix Endovascular Aneurysm Sealing System (the Nellix EVAS System).

Sales by Activity: Endologix, Inc.

Fiscal Period: December 2019 (USD)

Development, Manufacture, Marketing and Sale of EVAR and EVAS Products

143M

Geographical breakdown of sales: Endologix, Inc.

Fiscal Period: December 2019 (USD)

United States (U.S.)

95.32M

International

48.05M

Executive Committee: Endologix, Inc.

Manager TitleAgeSince
Chief Executive Officer 62 07/01/2025
Director of Finance/CFO - 01/09/2014
Chief Operating Officer - 18/06/2024
Chief Tech/Sci/R&D Officer - 01/02/2023
Sales & Marketing - 01/04/2025

Composition of the Board of Directors: Endologix, Inc.

Director TitleAgeSince
Director/Board Member - -
Director/Board Member 44 01/11/2020
Director/Board Member - -
Director/Board Member - -
Director/Board Member 48 24/08/2023
Director/Board Member 62 07/01/2025
Director/Board Member 69 25/01/2024
Director/Board Member 66 09/01/2024
Director/Board Member 61 09/07/2025

Company details: Endologix, Inc.

Endologix LLC

2 Musick

92618, Irvine

+(949) 595-7200

http://www.endologix.com
address Endologix, Inc.

Medical Devices & Implants

Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-2.88%-16.43%+19.59% 126B
-0.37%-2.42%-22.67%+0.75% 12.26B
0.00%+0.20%+96.38%+148.34% 10.9B
-4.90%-8.39%-52.04%-69.44% 4.14B
-0.43%-1.43%-24.31%+48.56% 2.69B
+1.78%+9.21%-35.03%-71.13% 1.8B
-1.13%-0.43%-23.65%-12.13% 1.66B
-3.68%-3.53%-35.52%-37.74% 1.61B
Average -1.02%-0.61%-14.16%+3.35% 20.18B
Weighted average by Cap. +0.23%-2.52%-10.80%+23.14%